Pemetrexed alone versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer: A systematic review.

Authors
Category Systematic review
JournalChinese Journal of New Drugs
Year 2011
This article has no abstract
Epistemonikos ID: ebc52c21de2192fb2c764da3dc9993262908bf59
First added on: Apr 03, 2019